Estela Castilla Ortega-rekin lankidetzan egindako argitalpenak (18)

2024

  1. Correction: Plasma concentrations of lysophosphatidic acid and the expression of its receptors in peripheral blood mononuclear cells are altered in patients with cocaine use disorders(Translational Psychiatry, 10.1038/s41398-023-02523-1)

    Translational Psychiatry

2023

  1. Plasma Lysophosphatidic Acid Concentrations in Sex Differences and Psychiatric Comorbidity in Patients with Cocaine Use Disorder

    International Journal of Molecular Sciences, Vol. 24, Núm. 21

  2. Plasma concentrations of lysophosphatidic acid and the expression of its receptors in peripheral blood mononuclear cells are altered in patients with cocaine use disorders

    Translational Psychiatry, Vol. 13, Núm. 1

2021

  1. Plasma concentrations of lysophosphatidic acid and autotaxin in abstinent patients with alcohol use disorder and comorbid liver disease

    Biomedicines, Vol. 9, Núm. 9

2020

  1. Abstinent patients with alcohol use disorders show an altered plasma cytokine profile: Identification of both interleukin 6 and interleukin 17A as potential biomarkers of consumption and comorbid liver and pancreatic diseases

    Journal of Psychopharmacology, Vol. 34, Núm. 11, pp. 1250-1260

  2. Cocaine-induced changes in CX3CL1 and inflammatory signaling pathways in the hippocampus: Association with IL1β

    Neuropharmacology, Vol. 162

2019

  1. Alcohol-induced cognitive deficits are associated with decreased circulating levels of the neurotrophin BDNF in humans and rats

    Addiction Biology, Vol. 24, Núm. 5, pp. 1019-1033

  2. Serotonin is the main tryptophan metabolite associated with psychiatric comorbidity in abstinent cocaine-addicted patients

    Scientific Reports, Vol. 9, Núm. 1

2018

  1. Higher impulsivity as a distinctive trait of severe cocaine addiction among individuals treated for cocaine or alcohol use disorders

    Frontiers in Psychiatry, Vol. 9, Núm. FEB

  2. Systemic blockade of LPA1/3 lysophosphatidic acid receptors by ki16425 modulates the effects of ethanol on the brain and behavior

    Neuropharmacology, Vol. 133, pp. 189-201

2017

  1. Decreased plasma concentrations of BDNF and IGF-1 in abstinent patients with alcohol use disorders

    PLoS ONE, Vol. 12, Núm. 11

  2. Plasma chemokines in patients with alcohol use disorders: Association of CCL11 (Eotaxin-1) with psychiatric comorbidity

    Frontiers in Psychiatry, Vol. 7, Núm. JAN

  3. Plasma concentrations of oleoylethanolamide and other acylethanolamides are altered in alcohol-dependent patients: effect of length of abstinence

    Addiction Biology, Vol. 22, Núm. 5, pp. 1366-1377

2016

  1. Cocaine-induced behavioral sensitization decreases the expression of endocannabinoid signaling-related proteins in the mouse hippocampus

    European Neuropsychopharmacology, Vol. 26, Núm. 3, pp. 477-492

2015

  1. Plasma Concentrations of BDNF and IGF-1 in abstinent cocaine users with high prevalence of substance use disorders: Relationship to psychiatric comorbidity

    PLoS ONE, Vol. 10, Núm. 3

  2. Sex differences in psychiatric comorbidity and plasma biomarkers for cocaine addiction in abstinent cocaine-addicted subjects in outpatient settings

    Frontiers in Psychiatry, Vol. 6, Núm. FEB

2014

  1. 1-Oleoyl lysophosphatidic acid: A new mediator of emotional behavior in rats

    PLoS ONE, Vol. 9, Núm. 1

2009

  1. Effects of medial prefrontal cortex lesions on anxiety-like behaviour in restrained and non-restrained rats

    Behavioural Brain Research, Vol. 201, Núm. 2, pp. 338-342